Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Jikei University School of Medicine |
---|---|
Information provided by: | Jikei University School of Medicine |
ClinicalTrials.gov Identifier: | NCT00133328 |
The JIKEI HEART Study has been designed to investigate whether concomitant treatment with valsartan, an angiotensin II receptor blocker (ARB), in addition to conventional treatment, will improve the prognosis of 3000 Japanese patients with cardiovascular diseases.
Condition | Intervention | Phase |
---|---|---|
Hypertension Ischemic Heart Disease Congestive Heart Failure |
Drug: valsartan |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | A Morbi-Mortality and Remodeling Study With Valsartan in Patients With Hypertension and Cardiovascular Disease |
Estimated Enrollment: | 3000 |
Study Start Date: | January 2002 |
Estimated Study Completion Date: | November 2005 |
Several recent clinical trials have demonstrated that angiotensin II receptor blockers (ARBs) have cardiovascular as well as renal protective effects. However, it is a problem that the number of Asian patients is very little in these trials. The researchers examine the treatment meaning by ARB about the prognosis of the patient who amalgamates either among high blood pressure, the ischemic heart disease, and congestive heart failures.
Ages Eligible for Study: | 20 Years to 79 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Japan | |
The Jikei University School of Medicine | |
Tokyo, Japan, 105-8461 |
Study Chair: | Seibu Mochizuki, MD., PhD | The Jikei University School of Medicine |
Study ID Numbers: | JHS2002 |
Study First Received: | August 22, 2005 |
Last Updated: | October 27, 2005 |
ClinicalTrials.gov Identifier: | NCT00133328 |
Health Authority: | Japan: Ministry of Health, Labor and Welfare |
stroke myocardial infarction angina renal damage |
Heart Failure Heart Diseases Cerebral Infarction Myocardial Ischemia Stroke Vascular Diseases |
Angina Pectoris Ischemia Infarction Myocardial Infarction Valsartan Hypertension |
Therapeutic Uses Cardiovascular Diseases Cardiovascular Agents Antihypertensive Agents Pharmacologic Actions |